Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
fuzheng jiedu quyu prescription
- Development stage
- Preclinical
- Lead developer
- Tianjin University of Traditional Chinese Medicine
- Administration
- Oral
01
Overview
Fuzheng Jiedu Quyu Prescription is a Traditional Chinese Medicine (TCM) herbal formula developed by researchers at the Tianjin University of Traditional Chinese Medicine. It is primarily investigated for the treatment of non-small cell lung cancer (NSCLC), typically administered in combination with standard Western palliative care. The formula is designed based on the TCM therapeutic principles of "Fuzheng" (strengthening the body's vital energy and immune resistance), "Jiedu" (detoxification and clearing heat), and "Quyu" (resolving blood stasis). Clinical research, including retrospective survival analyses, has evaluated the formula's efficacy in improving overall survival and quality of life for patients with advanced lung cancer by potentially modulating the tumor microenvironment and enhancing host anti-tumor immunity.
- Other names
- Fuzheng Jiedu Quyu FangFZJDQY
02
Targets
STAT3 (Signal Transducer and Activator of Transcription 3)Spike-ACE2 PPI (SARS-CoV-2 spike–ACE2 interface)Mpro (3C-like proteinase of SARS-CoV-2)PIK3CA (Phosphoinositide 3-kinase alpha)NLRP3 (Nod-like receptor family pyrin domain-containing protein 3)
Beyond the preview
Go deeper on fuzheng jiedu quyu prescription.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on fuzheng jiedu quyu prescription.